India Continuous Glucose Monitoring Devices Market Share, Outlook, Analysis and Report 2026-2034 | Get Sample Report

Source: IMARC Group | Category: Healthcare 

Report Introduction

According to IMARC Group’s latest report titled "India Continuous Glucose Monitoring Devices Market Size, Share, Trends and Forecast by Component, and Region, 2026-2034", this study offers a granular analysis of the nation's diabetes management landscape. This research report offers a profound analysis of the industry, encompassing market share, size, India continuous glucose monitoring devices market share, growth factors, key trends, and regional insights. The report covers critical market dynamics, including the shift from traditional finger-prick testing to real-time monitoring, the integration of AI-driven health analytics, and the increasing accessibility of CGMs through local manufacturing initiatives under "Make in India".

Market At-A-Glance: Key Statistics (2026-2034):

  • Current Market Size (2025): USD 240.6 Million
  • Projected Market Size (2034): USD 359.41 Million
  • Growth Rate (CAGR): 4.56%
  • Dominant Region: North India (Driven by high diabetes prevalence and advanced healthcare infrastructure in Delhi-NCR).

Request Free Sample Report (Exclusive Offer on Corporate Email): https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market/requestsample

India Continuous Glucose Monitoring Devices Market Overview

The India continuous glucose monitoring devices market size reached USD 240.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 359.41 Million by 2034, exhibiting a steady growth rate (CAGR) of 4.56% during 2026-2034.

The market is witnessing a paradigm shift in diabetes care, driven by the country's status as the "Diabetes Capital of the World." The transition from reactive management to proactive, real-time glucose tracking is accelerating, supported by the launch of affordable, factory-calibrated sensors. Hospitals and endocrinologists are increasingly prescribing CGMs not just for Type 1 diabetes patients but also for Type 2 patients to better manage glycemic variability. Furthermore, the integration of these devices with smartphones and cloud platforms allows for remote patient monitoring, a trend that gained immense traction post-pandemic and is now becoming standard practice in urban healthcare settings.

Top Emerging Trends in the India Continuous Glucose Monitoring Devices Market:

  • Shift from Fingerstick Testing to Real-Time Continuous Monitoring: Patients increasingly adopt CGM systems for real-time glucose visibility, trend alerts, and reduced fingerstick dependence, improving daily diabetes management and treatment adherence outcomes.
  • Rising Adoption of Smartphone-Integrated and App-Based CGM Systems: CGM devices increasingly sync with smartphones and cloud apps, enabling data sharing, analytics, remote monitoring, and personalized insights for patients and healthcare providers.
  • Growing Demand for Factory-Calibrated and Needle-Free Sensors: Manufacturers focus on factory-calibrated, minimally invasive sensors to improve comfort, accuracy, and ease of use, reducing patient burden and increasing long-term compliance.
  • Expansion of CGM Usage Beyond Type 1 Diabetes Patients: CGM adoption is expanding among Type 2 diabetics, gestational diabetes cases, and high-risk populations for preventive glucose monitoring and therapy optimization.
  • Increased Emphasis on Data Analytics and AI-Based Insights: Advanced analytics and AI tools are enhancing CGM value by predicting glucose trends, hypoglycemia risks, and therapy adjustments in real time.

India Continuous Glucose Monitoring Devices Market Growth Factors (Drivers)

  • Rising Prevalence of Diabetes and Pre-Diabetic Population: Increasing incidence of diabetes and pre-diabetes in India is driving demand for continuous, accurate glucose monitoring solutions.
  • Growing Awareness of Preventive and Proactive Diabetes Management: Patients and clinicians increasingly emphasize early intervention, tight glycemic control, and continuous monitoring to prevent long-term complications.
  • Improving Affordability and Entry of Cost-Competitive CGM Devices: Entry of newer players and local distribution partnerships is gradually improving CGM affordability and market accessibility.
  • Expansion of Digital Health Ecosystem and Telemedicine: Growth of teleconsultations and digital health platforms supports remote CGM data sharing and continuous patient engagement.
  • Increasing Physician Recommendations and Clinical Acceptance: Wider clinical acceptance and physician endorsements are accelerating CGM adoption across hospitals, clinics, and diabetes care centers nationwide.

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-continuous-glucose-monitoring-devices-market

Market Segmentation

Analysis by Component:

  • Sensors (Dominant segment due to recurring usage)
  • Durables (Receivers and Transmitters)

Regional Insights:

  • North India (Highest market share due to healthcare infrastructure)
  • West and Central India
  • South India
  • East India

India Continuous Glucose Monitoring Devices Market Recent Developments & News

  • August 2025: Abbott launched the FreeStyle Libre 2 Plus in India, offering real-time glucose monitoring with optional alarms for better safety.
  • June 2025: Tracky introduced India's first Bluetooth-enabled continuous glucose monitoring device, enhancing accessibility with a scan-free mobile app experience.
  • Strategic Partnerships: Global medical technology companies are collaborating with local players to introduce climate-suitable and affordable CGM solutions.

Why Buy This Report? (High-Value Insights)

  • Granular Segmentation: Detailed analysis of Sensor vs. Transmitter revenue streams, helping distributors manage inventory cycles effectively.
  • Regional Hotspots: In-depth breakdown of demand in Tier-1 vs. Tier-2 cities, identifying the next wave of adoption beyond the metros.
  • Future-Ready Trends: Insights into the commercial viability of Non-Invasive Glucose Monitoring, highlighting the next frontier of R&D.

Key Highlights of the Report

  • Market Forecast (2026-2034): Quantitative data on market value and steady growth trajectory.
  • Competitive Landscape: Comprehensive analysis of global giants versus emerging Indian startups.
  • Strategic Analysis: Porter’s Five Forces analysis and value chain assessment.
  • Technological Trends: Insights into advancements in sensor enzyme technology for better accuracy.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=43726&flag=E

Customization Note: If you require specific data we can provide it as part of our customization services.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-201971-6302